| Chemical | Toxicity Endpoint Type | Endpoint Description | Endpoint Value | Sample Size | Life Cycle Stage | Study Duration | Type |
|---|---|---|---|---|---|---|---|
| CRUDE OILS | TOX-Non-Repro-Sublethal - whole animal | growth rate, estimated as change in body weight, compared to control | decrease @ 5% | 50/dose | Juvenile | 8 wks | Toxicity Factor Datasets |
| CRUDE OILS | TOX-Non-Repro-Sublethal - behavioral effects | distance retreated from a frightening stimulus; impaired avoidance behavior | decrease @ 0.25 - 5% | 10/dose | Juvenile | 6 d | Toxicity Factor Datasets |
| CRUDE OILS | TOX-Non-Repro-Sublethal - cellular/biochemical effects | incidence of liver hypertrophy and splenic atropy | increase @ 2.5 - 5% | 10/dose | Juvenile | 8 wks | Toxicity Factor Datasets |
| CRUDE OILS | TOX-Non-Repro-Sublethal - organ/system effects | hematocrit, compared to control | decrease @ 2.5 - 5% | 10/dose | Juvenile | 8 wks | Toxicity Factor Datasets |
| CRUDE OILS | TOX-Non-Repro-Sublethal - cellular/biochemical effects | plasma alanine aminotransferase activity, from liver | increase @ 0.25 - 5.0% | 10/dose | Juvenile | 8 wks | Toxicity Factor Datasets |
| CRUDE OILS | TOX-Non-Repro-Sublethal - cellular/biochemical effects | pathological release of ornithine carbamyltransferase from kidney | increase @ 0.025 - 5% | 10/dose | Juvenile | 8 wks | Toxicity Factor Datasets |
| CRUDE OILS | TOX-Non-Repro-Sublethal - organ/system effects | incidence of degeneration of kidney tubules | increase @ 5% | 10/dose | Juvenile | 8 wks | Toxicity Factor Datasets |
